We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICR icon
2201
Vicor
VICR
$9.41B
$10.2K ﹤0.01%
93
+49
+111% +$4.17K
QDEL icon
2202
QuidelOrtho
QDEL
$1.15B
$10.1K ﹤0.01%
354
+30
+9% +$813
SNDR icon
2203
Schneider National
SNDR
$6.44B
$10.1K ﹤0.01%
380
-1,605
-81% -$37.9K
SPHR icon
2204
Sphere Entertainment
SPHR
$5.01B
$10.1K ﹤0.01%
187
+27
+17% +$2.06K
GLBE icon
2205
Global E Online
GLBE
$6.34B
$9.98K ﹤0.01%
254
NEGG icon
2206
Newegg Commerce
NEGG
$301M
$9.95K ﹤0.01%
196
AI icon
2207
C3.ai
AI
$1.37B
$9.92K ﹤0.01%
736
+68
+10% +$1.08K
TRVI icon
2208
Trevi Therapeutics
TRVI
$2.57B
$9.88K ﹤0.01%
789
HROW icon
2209
Harrow
HROW
$1.4B
$9.85K ﹤0.01%
201
HUN icon
2210
Huntsman Corp
HUN
$2.06B
$9.8K ﹤0.01%
980
+326
+50% +$2.98K
XNCR icon
2211
Xencor
XNCR
$1.47B
$9.77K ﹤0.01%
638
BSVN icon
2212
Bank7 Corp
BSVN
$472M
$9.67K ﹤0.01%
236
-112
-32% -$4.79K
TWO
2213
Two Harbors Investment
TWO
$1.27B
$9.66K ﹤0.01%
920
+860
+1,433% +$8.6K
VTWO icon
2214
Vanguard Russell 2000 ETF
VTWO
$17.4B
$9.65K ﹤0.01%
+97
New +$9.64K
IPI icon
2215
Intrepid Potash
IPI
$461M
$9.6K ﹤0.01%
346
+331
+2,207% +$8.9K
OFG icon
2216
OFG Bancorp
OFG
$2.21B
$9.59K ﹤0.01%
234
FER icon
2217
Ferrovial N.V. Ordinary Shares
FER
$45B
$9.56K ﹤0.01%
+149
New +$9.43K
CNMD icon
2218
CONMED
CNMD
$1.31B
$9.54K ﹤0.01%
235
+168
+251% +$7.31K
PPLI
2219
People Inc
PPLI
$3.15B
$9.46K ﹤0.01%
242
+23
+11% +$805
RGNX icon
2220
Regenxbio
RGNX
$622M
$9.42K ﹤0.01%
654
+528
+419% +$6.58K
WD icon
2221
Walker & Dunlop
WD
$1.69B
$9.38K ﹤0.01%
156
-1,947
-93% -$138K
EGBN icon
2222
Eagle Bancorp
EGBN
$858M
$9.38K ﹤0.01%
+438
New +$8.44K
BKU icon
2223
Bankunited
BKU
$3.36B
$9.36K ﹤0.01%
210
SVC
2224
Service Properties Trust
SVC
$1.08B
$9.35K ﹤0.01%
1,016
+878
+636% +$8.82K
CD
2225
Chaince Digital Holdings
CD
$242M
$9.34K ﹤0.01%
1,880
+744
+65% +$8.62K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.